Capsule Endoscopy in Inflammatory Bowel Disease: Evolving Role and Recent Advances.

Autor:	Eidler P; Gastroenterology Institute, Sheba Medical Center Tel Hashomer, Ramat Gan 52621, Israel., Kopylov U; Gastroenterology Institute, Sheba Medical Center Tel Hashomer, Ramat Gan 52621, Israel; Faculty of Medical and Health Sciences, Tel-Aviv University, Ramat Aviv, Tel Aviv 69978, Israel., Ukashi O; Gastroenterology Institute, Sheba Medical Center Tel Hashomer, Ramat Gan 52621, Israel; Faculty of Medical and Health Sciences, Tel-Aviv University, Ramat Aviv, Tel Aviv 69978, Israel. Electronic address: offirukashi@gmail.com.
Jazyk:	angličtina
Zdroj:	Gastrointestinal endoscopy clinics of North America [Gastrointest Endosc Clin N Am] 2025 Jan; Vol. 35 (1), pp. 73-102. Date of Electronic Publication: 2024 Sep 05.
DOI:	10.1016/j.giec.2024.07.002
Abstrakt:	Capsule endoscopy has been proven as an efficient and accurate tool in the diagnosing and monitoring patients with inflammatory bowel disease, especially Crohn's disease (CD). The current European Crohn's and Colitis Organization guidelines recommend small bowel disease assessment in newly diagnosed CD, wherein small bowel capsule endoscopy (SBCE) is of prime importance. SBCE plays an essential role in assessing mucosal healing in patients with CD, serving as a monitoring tool in a treat to target strategy, and is capable of identifying high-risk patients for future flares. Competing Interests: Disclosures U. Kopylov received speaker and consultancy fees from Abbvie, BMS, Elly Lilly, Celtrion, Medtronic, Janssen, Pfizer, Roche, and Takeda, and research support from Abbvie, Elli Lilly, Medtronic Takeda, and Janssen. The remaining authors declare that they have no conflicts of interest. (Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu